Evidence map›Paper›PMID 31242949›Full record

ArticleSubstance abuse treatment, prevention, and policy2019

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada.

Kristen A Morin, Joseph K Eibl, Joseph M Caswell, Graham Gauthier, Brian Rush, Christopher Mushquash, Nancy E Lightfoot, David C Marsh

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Kristen A MorinLaurentian University, Sudbury, Canada.
Joseph K EiblNorthern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada.
Joseph M CaswellInstitute of clinical and Evaluative Sciences, Sudbury, ON, Canada.
Graham GauthierNorthern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada.
Brian Rush, Centre for Addiction and Mental Health, Toronto, Canada.
Christopher MushquashNorthern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada.
Nancy E LightfootLaurentian University, Sudbury, Canada.
David C MarshNorthern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada. dmarsh@nosm.ca.
Centre for Addiction and Mental Health · CALaurentian University · CANOSM University · CAInstitute for Clinical Evaluative Sciences · CALakehead University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective was to characterize the relationship between geography, concurrent psychiatric services, all-cause mortality, and acute health care use for individuals enrolled in Opioid Agonist Treatment, in Ontario, Canada.

methodsWe conducted a propensity score matching study of patients enrolled in Opioid Agonist Treatment in Ontario for the first time between January 1, 2011, and December 31, 2015. We first compared outcomes between patients who were actively engaged and patients who were not actively engaged in Opioid Agonist Treatment. We created treatment and a control groups on the basis of an individual's access to psychiatric care within an episode of Opioid Agonist Treatment. Relative risk and number needed to treat were calculated to determine the correlation between psychiatric care and health outcomes among patients enrolled in Opioid Agonist Treatment at two time points within an episode of care and for two geographic regions in Ontario (north and south).

resultsDuring the first year of Opioid Agonist Treatment, concurrent psychiatric care was associated with a reduction in all-cause mortality in southern Ontario (RR 0.80, 95% CI, 0.73-0.87), a reduction in emergency department visits in both northern and southern Ontario (north: RR = 0.76, 95% CI, 0.72-0.81; south: RR = 0.87, 95% CI, 0.86-0.88), and a reduction in hospitalizations (north: RR = 0.88, 95% CI. 0.82-0.94, south: RR = 0.92, 95% CI, 0.91-0.93).

conclusionOur findings have significant clinical and political implications for health system planning highlighting the need for integrated mental health and addiction services for individuals with Opioid Use Disorder.

Indexed as

MortalityPropensity ScoreCohort StudiesEmergency Service, HospitalFacilities and Services UtilizationGeography, MedicalHospitalizationMental Health ServicesOntarioOpiate Substitution TreatmentOpioid-Related DisordersTime FactorsConcurrent Health servicesMental disordersMental Health servicesOpioid use disorderPsychiatryRural Health

Identifiers

PMID31242949
PMCPMC6595572
OpenAlexW2953895162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.